Polidocanol Sclerotherapy of Pharynges for Obstructive Sleep Apnea (OSA) and Snoring Subjects(SS)

Liaoyang Central Hospital

Status and phase: Unknown; Phase 2; Phase 1

Conditions: Snoring; Apnea

Treatments: Drug: Polidocanol Sclerotherapy

Study type: Interventional

Funder types: Other

Identifiers

NCT00399451

LYZXYY06002

ACTRNO12606000444583

Details and patient eligibility

About

The aim of this prospective study is to evaluate the results of polidocanol sclerotherapy of pharynx for OSAS & SS,to reduce pharyngeal compliance.

Full description

Polidocanol submucous sclerosis in the part of pharynges with 1% polidocanol injection.The injection should be in the retropharyngeal submucosa and lateral pharyngeal bands and lateral pharyngeal submucosa and in front submucosa of soft palate.The injection is multi-point,and each point injection is 0.3~0.5ml;the total quantity/each time is not more than 5ml.Every patient have to be treated about 1~2 time.

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• OSAS & SS which palatopharyngeal collapse.

Exclusion criteria

• obstructive sleep apnea syndrome (osas) & snoring subjects (ss),which anatomic narrow result in.

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)